Gene expression pattern contributing to prognostic factors in childhood acute lymphoblastic leukemia

Leukemia and Lymphoma

Volumn 54, Issue 2, 2013, Pages 310-314

  Silveira, Vanessa S ^a   Scrideli, Carlos Alberto ^a   Moreno, Daniel A ^a   Yunes, José Andres ^b   Queiroz, Rosane G P ^a   Toledo, Silvia C ^c   Lee, Maria Lúcia M ^c   Petrilli, Antonio S ^c   Brandalise, Silvia R ^b,d   Tone, Luiz Gonzaga ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Boldrini Institute   (Brazil)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^d UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

ALL; Chemotherapeutic agents; Gene expression profile; Treatment outcome

Indexed keywords

ASPARAGINASE; BILIVERDIN REDUCTASE B; BLOOD CLOTTING FACTOR 8; CADHERIN; CAENORHABDITIS ELEGANS PROTEIN; CD69 ANTIGEN; COAGULATION FACTOR VIII ASSOCIATED 1; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 2 ASSOCIATED PROTEIN 1; DAUNORUBICIN; EARLY GROWTH RESPONSE FACTOR 1; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 56; HERMES ANTIGEN; KCNN1 PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE 12; PREDNISOLONE; PROTEIN; PROTOCADHERIN 9; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; RIBOSOME PROTEIN; RIBOSOME PROTEIN P2; SHOC2 PROTEIN; SMALL CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR LIKE 5 PROTEIN; TRIPARTITE MOTIF CONTAINING 24; UNCLASSIFIED DRUG; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; BONE MARROW BIOPSY; CANCER PROGNOSIS; CANCER RESISTANCE; CANCER SURVIVAL; CHILD; CHILDHOOD LEUKEMIA; EVENT FREE SURVIVAL; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MICROARRAY ANALYSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SCHOOL CHILD; UPREGULATION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, LEUKEMIC; HUMANS; INFANT; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROGNOSIS;

EID: 84872048284     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2012.710330     Document Type: Article

References (30)

1. Pui CH, Carroll WL, Meshinchi S, et al. Biology, risk stratification, and therapy of pediatric acute leukemias: an update. JClin Oncol 2011; 29: 551-565.
2. Evans WE, Relling MV. Moving towards individualized medicine with pharmacogenomics. Nature 2004; 27: 464-468.
3. Kaspers GJL, Veerman AJP, Pieters R, et al. In vitro cellular drug resistance and prognosis in newly diagnosed childhood acute lymphoblastic leukemia. Blood 1997; 90: 2723-2729.
4. Flotho C, Coustan-Smith E, Pei D, et al. Aset of genes that regulate cell proliferation predicts treatment outcome in childhood acute lymphoblastic leukemia. Blood 2007; 15: 1271-1277.
5. Schmiegelow K, Nyvold C, Seyfarth J, et al. Post-induction residual leukemia in childhood acute lymphoblastic leukemia quantified by PCR correlates with in vitro prednisolone resistance. Leukemia 2001; 15: 1066-1071.
6. da Silva Silveira V, Canalle R, Scrideli CA, et al. Polymorphisms of xenobiotic metabolizing enzymes and DNA repair genes and outcome in childhood acute lymphoblastic leukemia. Leuk Res 2009; 33: 898-901.
7. Flohr T, Schrauder A, Cazzaniga G, et al. Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia. Leukemia 2008; 22: 771-782.
8. Yeoh EJ, Ross ME, ShurtleffSA, et al. Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell 2002; 1: 133-143.
9. Holleman A, Cheok MH, den Boer ML, et al. Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment. NEngl JMed 2004; 351: 533-542.
10. Scrideli CA, Assump o JG, Ganazza MA, et al. Asimplified minimal residual disease polymerase chain reaction method at early treatment points can stratify children with acute lymphoblastic leukemia into good and poor outcome groups. Haematologica 2009; 94: 781-789.
11. Brandalise SR, Pinheiro VR, Aguiar SS, et al. Benefits of the intermittent use of 6-mercaptopurine and methotrexate in maintenance treatment for low-risk acute lymphoblastic leukemia in children: randomized trial from the Brazilian Childhood Cooperative Group-protocol ALL-99. JClin Oncol 2010; 28: 1911-1918.
12. Brandalise SR. Prognostic value of day 8 peripheral blood response for children with acute lymphocytic leukemia. In Zander AR, editor. Gene technology: stem cell and leukemia research. Berlin: Spring-Verlag; 1996. pp. 421-428.
13. Livak KJ, Schmittgen TD. An alysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Methods 2001; 25: 402-408.
14. Pui CH, Evans WE. Treatment of acute lymphoblastic leukemia. NEngl JMed 2006; 354: 166-178.
15. Lugthart S, Cheok MH, den Boer ML, et al. Identification of genes associated with chemotherapy crossresistance and treatment response in childhood acute lymphoblastic leukemia. Cancer Cell 2005; 7: 375-386.
16. Holleman A, den Boer ML, de Menezes RX, et al. Theexpression of 70 apoptosis genes in relation to lineage, genetic subtype, cellular drug resistance, and outcome in childhood acute lymphoblastic leukemia. Blood 2006; 107: 769-776.
17. Sorich MJ, Pottier N, Pei D, et al. In vivo response to methotrexate forecasts outcome of acute lymphoblastic leukemia and has adistinct gene expression profile. PLoS Med 2008; 5: e83.
18. De PittC, Tombolan L, Campo Dell'Orto M, et al. Aleukemiaenriched cDNA microarray platform identifies new transcripts with relevance to the biology of pediatric acute lymphoblastic leukemia. Haematologica 2005; 90: 890-898.
19. Cario G, Fetz A, Bretscher C, et al. Initial leukemic gene expression profiles of patients with poor in vivo prednisone response are similar to those of blasts persisting under prednisone treatment in childhood acute lymphoblastic leukemia. Ann Hematol 2008; 87: 709-716.
20. Andersson CR, Lindgren D, Edn P, et al. Microarray-based classification of aconsecutive series of 121 childhood acute leukemias: prediction of leukemic and genetic subtype as well as of minimal residual disease status array-based classification of pediatric AML and ALL. Leukemia 1997; 21: 1198-1203.
21. Kirschner-Schwabe R, Lottaz C, Todling J, et al. Expression of late cell cycle genes and an increased proliferative capacity characterize very early relapse of childhood acute lymphoblastic leukemia. Clin Cancer Res 2006; 12: 4553-4561.
22. Selfors LM, Schutzman JL, Borland CZ, et al. Soc-2 encodes aleucine-rich repeat protein implicated in fibroblast growth factor receptor signaling. Proc Natl Acad Sci USA 1998; 95: 6903-6908.
23. Sieburth DS, Sun Q, Han M. SUR-8, aconserved Ras-binding protein with leucine-rich repeats, positively regulates Ras-mediated signaling in C. elegans. Cell 1998; 94: 119-130.
24. Li W, Han M, Guan KL. Theleucine-rich repeat protein SUR-8 enhances MAP kinase activation and forms acomplex with Ras and Raf. Genes Dev 2000; 14: 895-900.
25. Rodriguez-Viciana P, Oses-Prieto J, Burlingame A, et al. Aphosphatase holoenzyme comprised of Shoc2/Sur8 and the catalytic subunit of PP1 functions as an M-Ras effector to modulate Raf activity. Mol Cell 2006; 22: 217-230.
26. Robinson MJ, Cobb MH. Mitogen-activated protein kinase pathways. Curr Opin Cell Biol 1997; 9: 180-186.
27. Huang YZ, Zang M, Xiong WC, et al. Erbin suppresses the MAP kinase pathway. JBiol Chem 2003; 278: 1108-1114.
28. Pui CH, Relling MV, Downing Jr. Acute lymphoblastic leukemia. NEngl JMed 2004; 350: 1535-1548.
29. Conter V, Bartram CR, Valsecchi MG, et al. Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study. Blood 2010; 115: 3206-3214.
30. Bhojwani D, Kang H, Menezes RX, et al.; Children'sOncology Group Study; Dutch Childhood Oncology Group; German Cooperative Study Group for Childhood Acute Lymphoblastic Leukemia. Gene expression signatures predictive of early response and outcome in highrisk childhood acute lymphoblastic leukemia: aChildren'sOncology Group Study [corrected]. JClin Oncol 2008; 26: 4376-4384. Erratum in JClin Oncol 2008;26:5142.